ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ - Mollis Shanghai UniClub

ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ

 ÕÒ»ØÃÜÂë
 »¶Ó­¼ÓÈë һͬ×ÊѶ
http://www.danlan.org/new/UploadFile/201712/20171214/ea_20
http://www.danlan.org/new/UploadFile/201712/20171201/ea_20171211
http://www.danlan.org/new/UploadFile/20170
http://www.danlan.org/new/UploadFile/201712/20171212/ea_20171212221732992.jpg ɽÎ÷Ê¡ÎÀÉú¼
²é¿´: 1924|»Ø¸´: 0

Ñо¿·¢ÏÖ½üÁù³ÉHIV¸ÐȾŮÐÔδ×ñÒ½Öö

[¸´ÖÆÁ´½Ó]

378

Ö÷Ìâ

378

Ìû×Ó

1268

»ý·Ö

¹ÜÀíÔ±

Rank: 9Rank: 9Rank: 9

»ý·Ö
1268
·¢±íÓÚ 2018-9-25 09:29:40 | ÏÔʾȫ²¿Â¥²ã |ÔĶÁģʽ
¡¡¡¡AIDS Patient Care ST£º×îÐÂÑо¿ÏÔʾ£¬½üÁù³É°¬×̲¡Å®ÐÔ¸ÐȾÕßûÓÐ×ñÒ½Öö
¡¡¡¾º£ÄÏͬ־-ÈýÑÇͬ־»áËù¡¿¡¡Ò»ÏîеÄÑо¿±íÃ÷£¬ºÜ¶àHIV¸ÐȾŮÐÔûÓа´ÕÕ×î½üÖ¸ÄÏÖеÄÍÆ¼ö·þÒ©ËûÍ¡ÀàÒ©Îï¡£ÔÚHIVÑôÐÔ¸¾Å®ÖУ¬¿ØÖÆÑªÖ¬Ë®Æ½¶ÔÓÚÔ¤·ÀÐÄÔಡÓÈÆäÖØÒª£¬¶øÇÒËýÃÇÒ²¿ÉÄÜÊÜÒæÓÚËûÍ¡ÀàÒ©ÎïDZÔڵĿ¹Ñ××÷Óã¬Ñо¿±¨¸æ·¢±íÔÚ¡¶°¬×̲¡»¼Õß»¤ÀíºÍÐÔ²¡¡·ÉϵÄÎÄÕÂÖС£
¡¡¡¡À´×Ô±±¿¨ÂÞÀ´ÄÉ´óѧµÄÑо¿ÈËÔ±ÔÚ±¨¸æÖÐÖ¸³öÁËδ³ä·ÖÀûÓÃËûÍ¡ÀàÒ©Îï¶ÔHIVÑôÐÔÅ®ÐÔµÄÓ°Ïì¡£Ê×ÏÈ£¬Ñо¿ÈËÔ±¶ÔHIV¸ÐȾºÍδ¸ÐȾµÄ¸¾Å®Ê¹ÓÃËûÍ¡ÀàÒ©ÎïµÄÏêÇé½øÐжԱȣ¬·þÓÃËûÍ¡ÀàÒ©Îï5Äêºó£¬ÕâÁ½×鸾ٵĸÐȾÂʶ¼ºÜµÍ£¬ÆäÖУ¬HIV¸ÐȾÕߵϼ²¡ÂÊΪ38%¡£
¡¡¡¡Ð·¢²¼ËûÍ¡ÀàÒ©ÎïʹÓÃÖ¸ÄÏÖ®ºó£¬Å®ÐÔHIV¸ÐȾÕß·þÒ©ËûÍ¡ÀàÒ©ÎïµÄ±ÈÀý´Ó֮ǰ16%Ôö¼ÓÖÁ45%£¬È»¶ø£¬ÈÔÓнüÁù³ÉµÄ¸ÐȾÕßûÓзþÓÃËûÍ¡ÀàÒ©Îï¡£
¡¡¡¡Ñо¿ÈËÔ±±íʾ£º¡°ÔÚÃÀ¹ú£¬Ïà½ÏÓÚͬÄêÁäµÄÈË£¬°¬×̲¡²¡¶¾¸ÐȾÕßÓëÒ½ÁƱ£½¡ÌṩÕßµÄÁªÏµ¸ü¼Ó½ôÃÜ¡£È»¶ø£¬Èç¹ûHIV¸ÐȾÕßÏ£Íû´ïµ½Õý³£µÄÊÙÃü£¬¾ÍÐèÒªÍ»ÆÆºÜ¶àµÄÕϰ­£¬ÆäÖУ¬ÐÄѪ¹Ü¼²²¡ÊÇ×îÖØÒªµÄÕϰ­Ö®Ò»¡£ÓÉÓÚHIVµÄÌØÒìÐԺͱ仯ÐÔ£¬Ëü»á¸øÉíÌåµÄ¸÷¸öÆ÷¹ÙºÍ×éÖ¯´øÀ´¸÷ÖÖ¸÷ÑùµÄËðÉË£¬¼ÓËÙÓëË¥ÀÏÓйصļ²²¡£¬ÌرðÊÇÐÄѪ¹Ü¼²²¡£¬Òò´Ë£¬ÎÒÃǽ¨Òé°¬×̲¡¸ÐȾÕßÃÇ£¬ÓÈÆäÊÇÅ®ÐÔ£¬Ò»¶¨Ò©½÷×ñÒ½Öö£¬°´Ê±·þÒ©ËûÍ¡ÀàÒ©Î½«¿ÉÒÔÔ¤·ÀµÄ°¬×̲¡²¢·¢Ö¢·çÏÕ½µµÍµ½×îµÍÏÞ¶È¡£¡±
¡¡¡¡Ô­Ê¼³ö´¦£ºTodd Jonathan V., Cole Stephen R., Wohl David A., et.al. Underutilization of Statins When Indicated in HIV-Seropositive and Seronegative Women. AIDS Patient Care and STDs
¡¡¡¡(À´Ô´£ºMedSci)

»Ø¸´

ʹÓõÀ¾ß ¾Ù±¨

±¾°æ»ý·Ö¹æÔò

Archiver|ÊÖ»ú°æ|СºÚÎÝ|ÉϺ£Í¬Ö¾ - ÉϺ£Í¬Ö¾ÁÄÌìÊÒ - ÉϺ£Í¬Ö¾½»ÓÑ  

GMT+8, 2023-2-5 19:31 , Processed in 0.423024 second(s), 25 queries .

Powered by ͬ־´óȫվ¶ÔÓÚÈκΰüº¬ÓÚ¡¢¾­ÓÉ¡¢Á´½Ó¡¢ÏÂÔØ»ò´ÓÈκÎÓë±¾ÍøÕ¾ÓйطþÎñ£¨ÒÔϼò³Æ[·þÎñ]£©Ëù»ñµÃ µÄÐÅÏ¢¡¢ÄÚÈÝ»ò¹ã¸æ£¨ÒÔϼò³Æ[×ÊÁÏ]£©£¬²»ÉùÃ÷»ò±£Ö¤ÆäÕýÈ·ÐÔ»ò¿É¿¿ÐÔ¡£ÄúÓڴ˽ÓÊܲ¢³ÐÈÏÐÅÀµÈκΠ[×ÊÁÏ]Ëù·¢ÉúµÄ·çÏÕ¶¼Ó¦×ÔÐге£¡£¶ÔÓÚÒò[·þÎñ]¡¢[×ÊÁÏ]ËùÉúµÄÈκÎÖ±½Ó¡¢¼ä½Ó¡¢¸½´øµÄ»òÒò´Ë¶øµ¼Ö µÄÑÜÉúÐÔËðʧ¸Å²»¸ºÔð¡£ °²»ÕÍ¬Ö¾ÍøÕ¾ÎªÃâ·ÑÍøÖ·Õ¾£¬ËùÓÐÁ¬½Ó¾ùÀ´×ÔÍøÉÏ£¬ÆäÏà¹ØÄÚÈÝÒ»¸ÅÓë±¾Õ¾Î޹أ¬±¾Õ¾²»¶ÔÏà¹ØÍøÕ¾ÄÚÈÝ ¸ºÔð£¡ÈçÄú·¢ÏÖ±¾Õ¾ÓÐÈκηǷ¨²»Á¼Á¬½Ó,ÇëÁ¢¼´¸æÖ®ÎÒÃÇ,ÎÒÃǽ«ÔÚµÚһʱ¼äÄÚɾ³ý.ÎÒÃǼá¾öÖ§³ÖºÍÅä ºÏרÏîÐж¯ X3.2

© 2001-2013 Comsenz Inc.

¿ìËٻظ´ ·µ»Ø¶¥²¿ ·µ»ØÁбí